Infectious Coryza in Poultry

Etiology, Serotyping, Pathogenesis, Clinical Signs, Diagnosis, Treatment, and Control

A Veterinary Reference Guide for Poultry Producers and Flock Owners

Infectious coryza (IC) is an acute upper respiratory disease of chickens that has caused significant production losses in the poultry industry for over a century. Caused exclusively by Avibacterium paragallinarum, the disease is characterized by nasal discharge, facial swelling, and dramatic drops in egg production and growth performance. What makes infectious coryza particularly challenging to manage is the persistent carrier state it creates: birds that recover from infection remain carriers for life, silently harboring and shedding the bacterium without showing signs of illness and serving as a perpetual reservoir within and between flocks.

The disease occurs worldwide, with notable prevalence in California, the southeastern United States, Latin America, Asia, and Africa. A 2026 review published in Microorganisms (MDPI) by the Beijing Academy of Agriculture and Forestry Sciences describes IC as particularly severe under intensive farming conditions, significantly jeopardizing global poultry health and farming profitability. The same review notes that infection leads to growth retardation in broilers and egg production reductions of 10% or more in laying hens, reaching over 40% in some severe outbreaks. From a One Health perspective, the review also notes that disease-driven antibiotic use contributes to antimicrobial resistance concerns.

Quick Reference Summary

Category	Detail	Notes
Causative Agent	Avibacterium paragallinarum	Formerly Haemophilus paragallinarum; family Pasteurellaceae
Organism Type	Gram-negative, pleomorphic, non-motile, catalase-negative rod	Requires V factor (NAD) for culture growth
Serovars (Page scheme)	A, B, C	No cross-protection between serovars; vaccine must match local serovar
Serovars (Kume scheme)	A-1 to A-4, B-1, C-1 to C-4	Nine subtypes; used for more precise epidemiological tracking
Primary Hosts	Chickens only (confirmed)	Reports in quail/pheasants likely involve different organisms
Age Most Affected	Pullets and adult laying hens; all ages susceptible	Susceptibility increases with age
Transmission	Direct contact, nasal discharge, contaminated water/feed, airborne	No vertical (egg) transmission
Carrier State	Lifelong in recovered birds	The primary source of reintroduction into clean flocks
Incubation Period	24–72 hours	Rapid onset; high morbidity in susceptible flocks
Key Clinical Signs	Facial swelling, nasal discharge, sneezing, watery eyes	Egg production drops 10–40%+
Diagnosis	PCR of choanal/sinus swabs; bacterial culture with V-factor satellite test	PCR is faster and more sensitive than culture
Treatment	Antibiotics (sulfonamides, erythromycin, fluoroquinolones, tetracyclines)	Reduces signs; does not eliminate carrier state
Prevention	All-in/all-out management; vaccination matching local serovars	Vaccination is preventive, not curative
Eradication	Complete depopulation, cleaning, disinfection, restock with clean birds	Only reliable method to eliminate from premises
Zoonotic Risk	None documented	Avibacterium paragallinarum is not a human pathogen
Reportable?	Not federally reportable in U.S.	Report per state guidelines; document for flock records

1. Historical Background

Infectious coryza has been recognized as a distinct respiratory disease of chickens since the early 20th century. The causative organism was originally classified as Haemophilus paragallinarum based on its morphological and biochemical similarity to other Haemophilus species, particularly its requirement for the V factor (nicotinamide adenine dinucleotide, NAD) for growth. This classification persisted for decades and the organism is still frequently referenced in older literature under its former name.

A taxonomic reclassification in 2005 placed the organism in the newly created genus Avibacterium within the family Pasteurellaceae, reflecting improved genomic understanding of its true phylogenetic relationships. The Microorganisms 2026 review (Beijing Academy of Agriculture and Forestry Sciences) and the Merck Veterinary Manual both use the current designation Avibacterium paragallinarum. The organism’s unique requirement for V factor for culture has been a defining characteristic throughout its taxonomic history and remains a key feature used in laboratory identification.

The disease has been described as a significant production problem in laying flocks for most of the modern poultry industry era. The University of Maryland Extension FAQ (FS-1131, 2022) notes that IC cases are associated with improper management practices, particularly the practice of moving susceptible replacement pullets onto IC-infected multi-age layer facilities — a flock management error that remains among the most common causes of IC outbreak today.

2. Etiology and Classification

The Organism

The Merck Veterinary Manual describes Avibacterium paragallinarum as a gram-negative, pleomorphic, nonmotile, catalase-negative, microaerophilic rod. The organism requires nicotinamide adenine dinucleotide (V factor) for culture growth and does not require X factor (hemin), distinguishing it from other Haemophilus-like organisms. When A. paragallinarum is cultured on blood agar alongside a staphylococcal nurse colony that excretes V factor into the surrounding medium, the characteristic satellite colonies appear as dewdrop shapes growing adjacent to the nurse colony — a classic and practical field identification feature.

paragallinarum is a relatively fragile organism in the environment. The Poultry Hub Australia reference and the Hendrix Genetics review both note that the bacterium survives only 2–3 days outside the host under normal conditions, and is readily killed by heat, drying, and common disinfectants. This environmental fragility means that transmission requires relatively close contact between birds or with freshly contaminated materials. It also means that thorough cleaning and disinfection of premises is highly effective in eliminating the organism from the environment, making all-in/all-out management a reliable prevention strategy.

Serotyping: The Page and Kume Schemes

The serotypic diversity of A. paragallinarum is one of the most clinically important features of the disease because inactivated vaccines provide protection only against the serovar(s) they contain. Two serotyping schemes are currently used:

The Page Scheme: Developed by Page in 1962 using hemagglutination inhibition (HI) testing. Classifies A. paragallinarum into three serovars: A, B, and C. This remains the most widely used scheme in clinical practice and vaccine formulation globally. The Merck Veterinary Manual and the Frontiers in Veterinary Science 2026 study (South China Agricultural University) both describe the Page scheme as the standard reference framework.

The Kume Scheme: A more refined system that subdivides the three Page serogroups into nine serotypes: A-1, A-2, A-3, A-4, B-1, C-1, C-2, C-3, and C-4. The Microorganisms 2026 review (Beijing Academy) notes that the hemagglutinin gene HMTp210 is recognized as the primary molecular determinant of serotype in both schemes, with the hypervariable region 2 of HMTp210 correlating with serovar-specific immunity.

The critical clinical implication of this serotypic diversity is that no cross-protection exists between serovars A, B, and C. A flock vaccinated with a serovar A bacterin has no protection against challenge with serovar B or C strains, and vice versa. The University of Maryland Extension FAQ (2022) emphasizes that for vaccination to be effective, the serovar(s) present in the local population must be known, and vaccine formulation must match. This makes local surveillance and serotyping of outbreak isolates an ongoing necessity in IC-endemic regions.

The HMTp210 Hemagglutinin: Key Virulence and Diagnostic Antigen

The hemagglutinin protein HMTp210 is the principal surface antigen of A. paragallinarum and serves multiple functions critical to both pathogenesis and immunity. The Microorganisms 2026 review describes HMTp210 as a surface antigen pivotal in bacterial adhesion and infection, and as the prime target for subunit vaccines. The ScienceDirect study on HMTp210 (2014) characterizes it as a trimeric autotransporter adhesin that confers hemagglutination, cell adherence, and biofilm formation activities.

As the Avian Pathology journal study on HMTp210 characterization (Tandfonline, 2023) describes, analysis of the HMTp210 hypervariable region has emerged as a practical alternative to classical serotyping using antisera — which is laborious and requires scarce reference reagents. PCR-based HMTp210 genotyping can now distinguish all known serovars from clinical samples rapidly and reliably.

Other Virulence Factors

In addition to the hemagglutinin, the Microorganisms 2026 review identifies iron acquisition systems (including heme utilization), biofilm formation capacity, and adhesins as key contributors to A. paragallinarum’s ability to colonize the infraorbital sinus and nasal epithelium of chickens. The organism’s microaerophilic nature and its adaptation to the upper respiratory tract mucosa are central to its pathogenesis strategy.

3. Epidemiology and Transmission

Host Range and Geographic Distribution

The Merck Veterinary Manual states that infectious coryza apparently affects only chickens, and that reports in quail and pheasants likely describe a similar disease caused by a different bacterium. This strict host specificity is clinically relevant: in mixed-species operations, IC does not spread to turkeys, waterfowl, or other poultry species, unlike many other common respiratory pathogens. The PoultryDVM.com clinical resource confirms this chicken specificity and notes the disease’s worldwide distribution, with particular prevalence in California and southeastern U.S. regions, and extensive occurrence in Latin America, Asia, and Africa.

The University of Maryland Extension FAQ (2022) notes that IC cases may be more frequent in winter and fall seasons, though the disease can occur year-round. Seasonal patterns likely reflect management changes (moving replacement flocks, increased bird density in closed housing during cold months) rather than environmental effects on the organism itself, given the bacterium’s rapid environmental death outside the host.

Transmission Routes

paragallinarum is transmitted through several routes, all requiring relatively direct contact with infected birds or freshly contaminated materials:

Direct bird-to-bird contact, particularly through nasal and ocular secretions
Contaminated drinking water — a primary route in shared water systems
Contaminated feed and feeders
Airborne transmission over short distances has been reported; the University of Maryland Extension FAQ (2022) notes that transmission of infective particles in the air has been reported and the organism may also be able to spread over distances by the air
Contaminated equipment, clothing, and footwear of personnel moving between flocks

A critical distinction from several other important poultry pathogens: the University of Maryland Extension FAQ states clearly that IC is not transmitted through the eggs to hatched progeny. This means that IC is not a hatchery problem and cannot be introduced into a clean flock through chick procurement from a clean source. The introduction of infected or carrier birds into a clean flock is the primary route of entry onto new premises.

The Carrier State: The Core Epidemiological Challenge

The persistent carrier state is the most epidemiologically significant feature of infectious coryza and the primary driver of disease persistence on farms. The Merck Veterinary Manual, the University of Maryland Extension FAQ, the Poultry Hub Australia reference, and the PoultryDVM.com clinical resource all consistently state that recovered birds remain carriers for life. The University of Maryland Extension states this explicitly: recovered birds mostly serve as carriers for life.

Carrier birds show no clinical signs but continuously shed A. paragallinarum in nasal secretions, maintaining a reservoir of infection within the flock. The Poultry Hub Australia reference notes that once a flock is infected, all birds must be considered as carriers. This has profound implications for management: antimicrobial treatment of an infected flock may resolve the acute disease, but it does not eliminate the carrier state. Birds treated back to apparent health remain lifelong shedders.

The University of Maryland Extension FAQ identifies moving susceptible replacement pullets onto IC-infected multi-age layer facilities as among the most common management errors leading to IC outbreaks. When young, immunologically naïve replacement birds are introduced into housing previously occupied by carrier birds — even after cleaning — without adequate biosecurity, the risk of transmission is very high.

4. Pathogenesis

Following exposure, A. paragallinarum colonizes the mucous membranes of the nasal passages and infraorbital sinuses. The Microorganisms 2026 review (Beijing Academy) describes the organism’s colonization strategies as targeting the infraorbital sinus and nasal epithelium of chickens specifically, with the HMTp210 adhesin mediating attachment to the respiratory epithelium.

The incubation period is notably short — the PoultryDVM.com clinical resource states that susceptible birds typically develop clinical signs within 24 to 72 hours of exposure. The rapid onset reflects the organism’s efficient colonization of the upper respiratory mucosa and the rapid local inflammatory response triggered by bacterial products.

Once established in the sinuses and nasal passages, A. paragallinarum stimulates intense local inflammation, producing the characteristic swelling of the sinuses and infraorbital tissues. Mucus and exudate accumulate in the nasal passages and sinuses, producing the characteristic discharge. In severe cases, the inflammatory process extends to the lower respiratory tract, conjunctiva, and — in rare but documented cases — even to the middle ear and cranial bones.

A 2018 case report published in the Journal of Veterinary Diagnostic Investigation (Crispo et al., California Animal Health and Food Safety Laboratory / UC Davis) described an unusual presentation of IC in commercial broilers in which A. paragallinarum caused severe otitis media and interna, cranial osteomyelitis, and ascending meningoencephalitis — producing neurological signs including disorientation, torticollis, and opisthotonus. The organism was isolated from the upper and lower respiratory tract, brain, and cranial bones, demonstrating that while IC is primarily an upper respiratory disease, severe or atypical cases can produce invasive CNS involvement.

The PoultryDVM.com review also notes that co-infection with other pathogens is common and increases IC severity. Concurrent Ornithobacterium rhinotracheale infection in particular has been shown to dramatically worsen clinical signs compared to either pathogen alone.

5. Clinical Signs

Acute Form

The Merck Veterinary Manual describes the characteristic clinical presentation as decreased activity, nasal discharge, sneezing, and facial swelling. The PoultryDVM.com clinical resource provides the following detailed progression:

Depression and reduced feed and water consumption — often the earliest observable signs
Watery eyes (lacrimation) and mild nasal discharge in early disease
Progressive facial swelling as inflammatory exudate accumulates in the infraorbital sinuses — producing the characteristic “swollen face” appearance that is the hallmark clinical sign
Swelling of the wattles, particularly in males
Mucopurulent (thick, pus-like) nasal and ocular discharge as the disease advances
Sneezing and rattling respiratory sounds
Diarrhea in some cases
Difficulty breathing from nasal passage obstruction in severe cases

Production Losses

The impact on production is a defining economic feature of IC. The Microorganisms 2026 review states that infection leads to a 10% reduction in egg production on average, reaching over 40% in laying hens in severe outbreaks. Growth retardation in broilers is also documented. Egg production declines typically begin within days of the onset of clinical signs and may persist for weeks after clinical recovery, particularly in flocks with concurrent infections or secondary complications.

Chronic and Carrier State

As described in Section 3, birds that recover from clinical IC become lifelong carriers. The carrier state produces no clinical signs but represents an ongoing management and biosecurity challenge. Chronic IC in endemically infected multi-age flocks may produce a pattern of recurring low-level respiratory disease, mild facial swelling in newly introduced susceptible birds, and persistent but uneven production losses that are difficult to attribute to a single cause without diagnostic investigation.

Atypical Presentations

The case report by Crispo et al. (Journal of Veterinary Diagnostic Investigation, 2018) documented neurological signs — disorientation, torticollis, and opisthotonus — in commercial broilers with IC complicated by ascending meningoencephalitis. While this presentation is uncommon, it illustrates the potential for A. paragallinarum to cause more severe systemic disease, particularly in young birds with heavy upper respiratory infection that allows the organism to ascend through anatomical pathways to the middle ear and central nervous system.

6. Gross Pathology and Post-Mortem Findings

Post-mortem examination of birds with IC typically reveals the following:

Swollen, fluid-filled infraorbital sinuses — the most consistent gross finding; sinus exudate ranges from serous (watery) in early disease to caseous (cheese-like) in chronic cases
Mucopurulent discharge in the nasal passages and choanal cleft
Conjunctivitis and periorbital swelling
Edema of the face and wattles
In severe cases: fibrinous airsacculitis, particularly when secondary pathogens are involved
In the neurological presentation (Crispo et al., 2018): severe sinusitis, cranial osteomyelitis, otitis media and interna, and meningoencephalitis on histopathology

The Hendrix Genetics reference notes that sinus exudate smeared on a microscope slide and Gram stained will reveal gram-negative bipolar staining rods with a tendency toward filament formation and pleomorphism — a characteristic microscopic appearance consistent with A. paragallinarum.

7. Diagnosis

Presumptive Diagnosis

The Merck Veterinary Manual states that presumptive diagnosis is based on typical clinical signs in susceptible chickens, particularly the characteristic facial swelling and nasal discharge in laying-age birds. The University of Maryland Extension FAQ confirms that a thorough flock history, clinical signs, and gross lesions are usually enough to support a suspect diagnosis of IC, given the distinctive presentation.

Key features that support a presumptive diagnosis include: the chicken-only host specificity; the rapid onset (24–72 hours); the characteristic facial and sinus swelling; a history of recent introduction of new birds onto the premises; multi-age flock management in an area where IC is endemic; and a pattern of disease spreading progressively through the flock over days to weeks.

Bacterial Culture and V-Factor Test

Definitive diagnosis by culture requires aseptic collection of sinus exudate or choanal cleft swabs from birds in the acute stage of illness. The Merck Veterinary Manual describes the characteristic culture appearance: when grown on blood agar with a staphylococcal nurse colony that excretes V factor, A. paragallinarum produces satellite colonies appearing as dewdrop shapes adjacent to the nurse colony. The University of Maryland Extension FAQ notes that bacterial isolation from aseptically collected sinus exudate is technically challenging and may require specialist laboratory support.

The catalase-negative character of A. paragallinarum is a critical distinguishing feature. The Wixbio clinical guide notes that catalase-specific testing is essential because catalase-positive non-pathogenic organisms are present in both healthy and diseased chickens and can confound identification if catalase status is not determined.

PCR Assay

PCR testing has become the preferred diagnostic method for IC because of its superior sensitivity and speed compared to culture. The Merck Veterinary Manual states that diagnosis is confirmed by PCR assay or bacterial culture, listing PCR first. The University of Maryland Extension FAQ identifies PCR of choanal cleft or sinus swabs as one of the most typical definitive diagnostic methods. PCR assays targeting species-specific gene sequences in A. paragallinarum allow reliable detection from swab samples submitted to veterinary diagnostic laboratories, without the V-factor culture requirements.

HMTp210 Genotyping for Serovar Identification

As described in Section 2, classical serotyping by hemagglutination inhibition (HI) is laborious and requires scarce reference antisera. The Avian Pathology study (Tandfonline, 2023) demonstrated that PCR-based sequence analysis of the HMTp210 hypervariable region is a practical alternative to classical serotyping that can distinguish all nine Kume serovars and the three Page serovars. This method is increasingly available at veterinary diagnostic laboratories and is particularly valuable for matching outbreak isolates to appropriate vaccine serovars.

Differentiating IC from Other Respiratory Diseases

Several other conditions can produce similar facial swelling and respiratory signs and must be differentiated from IC. The Merck Veterinary Manual and PoultryDVM.com note that swollen head syndrome (caused by avian metapneumovirus combined with secondary bacterial infections), Newcastle disease, infectious laryngotracheitis, and mycoplasmosis can all produce overlapping clinical signs. The rapid 24–72-hour onset, the chicken-specific host range, the characteristic sinus swelling, and definitive laboratory confirmation distinguish IC from these other conditions.

8. Treatment

Infectious coryza can be treated with antibiotics, and early antimicrobial intervention significantly reduces morbidity and production losses. The Merck Veterinary Manual states that early antimicrobial treatment can help infected birds recover. However, a critical limitation must be understood: antimicrobial treatment resolves clinical signs and reduces bacterial shedding during the acute phase, but does not eliminate the carrier state. Recovered and treated birds remain lifelong carriers.

Antimicrobial Options

Antimicrobials with documented efficacy against A. paragallinarum include:

Sulfonamides: Among the most commonly used agents, administered in water or feed. Trimethoprim-sulfonamide combinations are frequently used and effective.
Erythromycin: Effective in many regions and historically a first-line agent for IC. The Wixbio clinical guide references erythromycin as one of the primary treatment antibiotics.
Tetracyclines (oxytetracycline): Widely used; can be administered in water or feed. The Wixbio guide references oxytetracycline. The Indonesia antimicrobial sensitivity study (Veterinary World, 2021, cited in the Merck Veterinary Manual) evaluated tetracycline sensitivity in A. paragallinarum isolates.
Fluoroquinolones: Highly effective; subject to regulatory restrictions in food-producing animals in many countries including the United States, where enrofloxacin is not approved for poultry.
Amoxicillin and ampicillin: Generally effective; water-soluble formulations available for poultry.

The Hendrix Genetics reference emphasizes that bacterial culture and antibiotic sensitivity testing should guide treatment selection, as antimicrobial resistance patterns vary by region. The Poultry Science 2024 study (cited in Merck Veterinary Manual references) examining antimicrobial resistance in Chinese A. paragallinarum isolates found variable resistance profiles, underscoring the need for regional surveillance and sensitivity-guided therapy rather than empirical treatment alone.

Important Treatment Limitations

The University of Maryland Extension FAQ notes that in areas where the disease is more frequent and widespread, treatment with antibiotics through feed or drinking water is used to reduce morbidity; however, recurrence may still occur once treatment is stopped because recovered birds remain carriers. The Wixbio guide confirms that in severe IC outbreaks, even if treatment results improve, recurrence may occur once treatment is stopped because recovered birds are still carriers. Treatment should always be accompanied by a plan to address the underlying management factors and carrier bird population.

9. Prevention and Control

The Merck Veterinary Manual states unequivocally that prevention is the only sound method of control for infectious coryza. Because antimicrobial treatment does not eliminate the carrier state, the management goal is to prevent introduction of A. paragallinarum into clean flocks and to maintain clean status through rigorous biosecurity.

All-In/All-Out Management

The Merck Veterinary Manual, the Poultry Hub Australia reference, and the University of Maryland Extension FAQ all identify all-in/all-out management as the foundational prevention strategy. Under this system:

An entire poultry house is populated with a single age group at one time
All birds are depopulated simultaneously at the end of the production cycle
The house is thoroughly cleaned, disinfected, and left empty for a minimum resting period before restocking
New birds are sourced exclusively from IC-free flocks or NPIP-tested clean sources
No birds are added to an existing flock partway through the production cycle — the practice of introducing replacement pullets to an older multi-age flock is one of the primary risk factors for IC

Given that A. paragallinarum survives only 2–3 days in the environment and is readily killed by disinfectants, a properly executed cleanout and rest period is highly effective in eliminating the organism from a contaminated premise, provided all carrier birds have been removed.

Biosecurity

Quarantine all new birds: A minimum 30-day isolation period for any incoming birds, regardless of source documentation. Birds should be observed for respiratory signs, and diagnostic testing (PCR swabs) should be conducted before introduction to the main flock.
Source birds from IC-free flocks: The University of Maryland Extension FAQ recommends ensuring that replacement birds are not infected before introduction. NPIP-participating hatcheries that test for A. paragallinarum provide the strongest guarantee.
Avoid mixed-age housing: Multi-age layer operations with carrier birds in older flocks represent the highest-risk scenario for IC transmission to susceptible replacement pullets. Single-age, all-in/all-out management eliminates this risk.
Limit visitor access: Personnel moving between flocks can mechanically carry A. paragallinarum on clothing and footwear. The PoultryDVM.com resource advises avoiding participation in poultry shows, auctions, or other events where birds may be exposed to outside flocks.
Rodent and wild bird control: While A. paragallinarum is host-specific to chickens, rodents and wild birds can mechanically transport infective secretions between premises.

Vaccination

Vaccination is an important tool for IC prevention in endemic regions or on farms with a documented history of IC. However, the Merck Veterinary Manual emphasizes a critical limitation: vaccines are only effective against the serovar(s) they contain, and no cross-protection exists between serovars A, B, and C. The University of Maryland Extension FAQ notes that vaccination should be based on knowledge of the serovar(s) present in the local population.

Inactivated whole-cell bacterins: The current standard of care. Available as bivalent (A+C) or trivalent (A+B+C) formulations. The Frontiers in Veterinary Science 2026 study and the PMC characterization study (Journal of Animal Science, 2023) both note that inactivated whole-cell vaccines against A. paragallinarum provide serovar-specific protection. The 2023 isolate characterization study documented a highly virulent serovar C strain (ZJ-C) against which the standard Modesto serovar C reference vaccine provided only 70% protection, underscoring the need for regional strain characterization and the potential value of autogenous vaccines from local isolates.

Live attenuated vaccine candidates: The PMC study (2025, Development and Evaluation of an Attenuated A. paragallinarum Strain) described a promising live vaccine candidate that provided 90% immunoprotection against homologous challenge in specific-pathogen-free chickens. Live attenuated vaccines could potentially offer advantages in inducing local mucosal immunity — which is particularly relevant for a pathogen that infects the respiratory mucosa — but are not yet commercially available.

Subunit vaccine research: The Microorganisms 2026 review describes HMTp210 as the prime target for subunit vaccines, with recombinant proteins containing the hypervariable region showing 83–100% protection against homologous serovar challenge in experimental studies. Subunit vaccines targeting HMTp210 represent the most advanced current area of IC vaccine research.

The PoultryDVM.com guide notes that vaccination is typically administered via intramuscular injection, often on a biannual schedule depending on risk. Vaccination is preventive, not curative — it must be administered to susceptible birds before exposure to provide protection. Vaccinating an already-infected or carrier flock will not eliminate the infection.

Eradication from an Infected Premises

The Poultry Hub Australia reference states plainly that complete depopulation followed by thorough cleaning and disinfecting is the only means for eliminating the disease from an infected premise. This is consistent with the lifelong carrier nature of recovered birds — as long as carrier birds remain on the premises, the risk of ongoing transmission to susceptible birds persists. Given the organism’s fragility outside the host and its susceptibility to routine disinfectants, a properly executed depopulation and cleanout provides a reliable path to disease-free status, provided new birds are sourced from confirmed IC-free flocks.

10. Zoonotic Considerations

Avibacterium paragallinarum is not known to be a human pathogen. No documented cases of human infection with A. paragallinarum exist in the published medical literature, and the organism’s strict host specificity for chickens — a result of its specific growth requirements, including V-factor dependency and microaerophilic conditions — makes human infection biologically implausible under normal exposure conditions.

Standard personal hygiene practices when handling sick birds or sinus exudates are appropriate — handwashing after handling birds and avoiding contact between facial mucous membranes and poultry secretions — but these are general infection control measures rather than specific protections against IC zoonosis.

11. What This Means for Backyard and Small Flock Owners

Infectious coryza can affect backyard and small farm flocks, particularly those that have introduced new birds from unknown sources, attended poultry shows or auctions, or share equipment with other flock owners. The disease’s carrier state makes IC very easy to inadvertently introduce and very difficult to eliminate once established without complete depopulation.

Key Points for Flock Owners

Facial swelling and nasal discharge in adult chickens — especially if it spreads through the flock within days — should always prompt veterinary consultation. Rapid onset and chicken-specific spread are hallmarks of IC.
Source birds carefully. Purchasing birds from NPIP-tested, documented IC-free sources is the most reliable protection. Avoid acquiring birds from auctions, swap meets, or flocks of unknown health status.
Never add new birds directly to an existing flock. A minimum 30-day quarantine period in a separate, physically isolated facility allows respiratory disease signs to appear and provides opportunity for diagnostic testing before integration.
Treatment reduces signs but not carrier status. If IC is diagnosed and treated, understand that recovered birds will remain carriers permanently. Any new susceptible birds introduced to the flock will be at risk of infection from these carrier birds.
If IC is confirmed, seriously consider depopulation. This is the only reliable way to eliminate IC from the premises. Continuing to manage an infected flock with treatment cycles is a long-term economic and animal welfare burden.
In endemic areas, vaccination is a practical mitigation tool. If IC is prevalent in your area or has occurred on your premises previously, consult a veterinarian about a vaccination program using a product containing the serovar(s) present locally.